SUMMARY. Plasma C1 inhibitor (Cl-INH) was determined in 64 patients with different malignant diseases and in 58 healthy persons. C1-INH antigen concentration was measured by radial immunodiffusion (RID), whereas its functional activity was assayed with chromogenic substrate. Within-run and day-to-day precision of both methods were good, with CVs ranging from 3.6 to 5.4%. Plasma C1-INH antigen concentrations were significantly higher in the patients than in healthy controls ( P = 4 -O x as were their Cl-INH functional activities ( P = 3 -5 x Cl-INH activities obtained in the patient plasma samples were in correlation with their antigen concentrations (r = 0.914), showing that C1-INH synthesized in malignant disease was functional. However, the specific activity of the C1-INH (functional activitylantigen concentration ratio) was significantly lower in the patient group as compared with the controls ( P = 2 . 1 x indicating partial inactivation of plasma C1-INH in malignant diseases. The Cl-INH specific activity in patients was inversely proportional to its antigen concentration.
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C1 inhibitor (Cl-INH) is a principal regulator of the classical pathway of complement activation, which inhibits active serine proteases: C l s (EC 3.4.21.42 ) and C l r (EC 3.4.21.41 C 1-INH antigen concentration was an essential prognostic parameter of gastric carcinoma.
In the present study, we measured plasma Cl-INH antigen concentration in 58 healthy subjects and in 64 patients with different malignant diseases, using radial immunodiffusion (RID). To examine whether the C1-INH elevation was accompanied by an adequate increase of its functional activity, we also assayed plasma C1-INH activities in controls and the patients using chromogenic substrate, and then calculated specific activities of Cl-INH, defined as the functional activity/antigen concentration ratio.
MATERIALS AND METHODS

Plasma samples
The patient group consisted of 64 subjects with various malignant diseases (41 solid tumours, 5 plasmacytomas, 13 lymphomas and 5 leukaemias) who had not undergone surgery or received any therapy for four months prior to study. The control group consisted of 58 healthy blood donors of both sexes.
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Blood was sampled preprandially using sodium citrate (0.11 mol/L) as anticoagulant (one volume of citrate was mixed with nine volumes of blood). Plasma was separated by centrifugation (1500 g for 15 min) and aliquots stored at -2O"C, not longer than two weeks. Samples were thawed only once, for analysis.
Apparatus, reagents and procedures C 1-INH antigen concentration was measured by radial immunodiffusion using NOR-Partigen immunodiffusion plates (Behringwerke AG, Marburg, Germany). Functional activity was assayed with chromogenic substrate using Behringwerke reagents Berichrom C1-Inactivator; after C1 inhibition with C1-INH from the plasma sample, residual C1 activity was determined and expressed as percent of normal. The measurements were performed with Behring ChromoTimeSystem (CTS).
Statistical methods
The results were analysed by using the STATGRAPHICP statistical software (Statistical Graphics Corporation, USA). Cl-INH values for patients were compared with healthy controls using Student's t-test. The functional C1-INH activities were correlated with antigen concentrations using linear regression analysis, for controls and patients separately. To express the properties of the Cl-INH in the two groups, we calculated the Cl-INH specific activity, defined as the functional activity (%)/antigen concentration (g/L) ratio. The specific activities in patients and controls were also correlated with the corresponding C 1 -1NH antigen concentrations by use of linear regression analysis.
RESULTS
We determined within-run and day-to-day precision of both plasma Cl-INH assays: chromogenic 
DISCUSSION
Plasma C 1 -1NH antigen concentration and functional activity was measured with good precision: coefficients of variation ranged from 3.6 to 5 *4% ( Table 1) . Patients suffering from various malignant diseases had significantly higher C 1-INH antigen concentrations than healthy controls ( plasmacytomas; A , lymphomas; and +, leukaemias. functionally active. Our results showed that C1-INH activity was higher in the patient than in the control group and that (Fig. lb) who also measured C1 -antigen concentration by radial immunodiffusion and its activity with chromogenic substrate in plasma samples from patients with angioedema and lung malignomas. They found increased C 1 -1NH concentration, but normal functional activity, and hypothesized that non-functional Cl-INH molecules were synthesized or an inactive complex formed. Although our results showed good correlation between C 1-INH activity and concentration in both patient ( r = 0 . 9 1 4 ) and control group (r=0.838), the specific activity of the Cl-INH was very significantly lower in patients, as compared with the healthy controls ( P = 2.1 x Fig. lc (Figs 1 and a) , StarhviC, JeliC-IvanoviC and Kalimanovska but a greater number of patients should be investigated to perform meaningful statistical analysis. The regression analysis of C1-INH specific activity against antigen concentration showed that the proportion of inactive C1-INH molecules was greater in patients with higher antigen concentrations (Fig. 2 ).
In conclusion, we have shown that both plasma C 1 -1NH antigen concentration and functional activity were significantly elevated in patients with malignant diseases. Although the activity correlated well with antigen concentration, C1-INH in patients was not fully active, the inactivation being more pronounced in subjects with higher antigen concentrations.
